Flávia Heinz Feier
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Flávia Heinz Feier has a total of 162 co-authors. Here are the top co-authors by number of shared publications:
- Joao Seda Neto
Hepatology and Liver Transplantation Hospital Sírio‐Libanês São Paulo Brazil
9 shared publications Paulo Chapchap
Hepatology and Liver Transplantation, Hospital Sírio-Libanês, São Paulo, Brazil
7 shared publications- Eduardo Antunes Fonseca
Hepatology and Liver Transplantation Hospital Sírio‐Libanês São Paulo Brazil
6 shared publications - Gilda Porta
Hepatology and Liver Transplantation Hospital Sírio‐Libanês and Hospital Samaritano São Paulo Brazil
6 shared publications - Irene Kazue Miura
Hepatology and Liver Transplantation Hospital Sírio‐Libanês and Hospital Samaritano São Paulo Brazil
5 shared publications Renata Pugliese
Hepatology and Liver Transplantation, Hospital Sírio-Libanês, Rua Barata Ribeiro, 414, cj 65, Bela Vista, SP, Brazil; Hepatology and Liver Transplantation, A. C. Camargo Cancer Center, São Paulo, SP, Brazil; Hospital Municipal Infantil Menino Jesus, São Paulo, SP, Brazil
5 shared publications
Latest Publications
- Open Access
- 9 November 2026
- Published by Associacao Brasileira de Transplantes de Orgaos in Brazilian Journal of Transplantation
- p. e4826
Abordagem Multidisciplinar da Obesidade Pós-Transplante Hepático: Desafios e Perspectivas Terapêuticas
Resumo: A transição epidemiológica elevou a doença hepática esteatótica associada à disfunção metabólica a uma das principais indicações de transplante hepático, enquanto a imunossupressão contínua favorece o ganho ponderal e complicações metabólicas no pós-operatório. O objetivo deste trabalho é discutir a relevância da estruturação de atendimentos especializados multidisciplinares para o manejo da obesidade e da síndrome metabólica após o transplante hepático. A partir do acompanhamento prospectivo de pacientes adultos submetidos ao procedimento, avaliou-se o perfil antropométrico, metabólico e os resultados de uma intervenção integrada entre cirurgia, endocrinologia, nutrição e hepatologia. Os dados demonstraram redução estatisticamente significativa do índice de massa corporal e melhora do controle glicêmico. Contudo, persistem gargalos importantes, especialmente a limitação de acesso a medicamentos anti-obesidade de alta eficácia na rede pública de saúde e a necessidade de definir o papel da cirurgia bariátrica em casos selecionados. Conclui-se que o cuidado multidisciplinar especializado é eficaz na otimização metabólica pós-transplante, reforçando a importância de ampliar estratégias terapêuticas farmacológicas e cirúrgicas para assegurar a longevidade do enxerto.
- 9 November 2026
- Published by Associacao Brasileira de Transplantes de Orgaos in Brazilian Journal of Transplantation
- p. e4826
Open AccessAbordagem Multidisciplinar da Obesidade Pós-Transplante Hepático: Desafios e Perspectivas Terapêuticas
Resumo: A transição epidemiológica elevou a doença hepática esteatótica associada à disfunção metabólica a uma das principais indicações de transplante hepático, enquanto a imunossupressão contínua favorece o ganho ponderal e complicações metabólicas no pós-operatório. O objetivo deste trabalho é discutir a relevância da estruturação de atendimentos especializados multidisciplinares para o manejo da obesidade e da síndrome metabólica após o transplante hepático. A partir do acompanhamento prospectivo de pacientes adultos submetidos ao procedimento, avaliou-se o perfil antropométrico, metabólico e os resultados de uma intervenção integrada entre cirurgia, endocrinologia, nutrição e hepatologia. Os dados demonstraram redução estatisticamente significativa do índice de massa corporal e melhora do controle glicêmico. Contudo, persistem gargalos importantes, especialmente a limitação de acesso a medicamentos anti-obesidade de alta eficácia na rede pública de saúde e a necessidade de definir o papel da cirurgia bariátrica em casos selecionados. Conclui-se que o cuidado multidisciplinar especializado é eficaz na otimização metabólica pós-transplante, reforçando a importância de ampliar estratégias terapêuticas farmacológicas e cirúrgicas para assegurar a longevidade do enxerto.
- Open Access
- 9 November 2026
- Published by Associacao Brasileira de Transplantes de Orgaos in Brazilian Journal of Transplantation
- p. e4826
Multidisciplinary Approach to Post-Liver Transplant Obesity: Challenges and Therapeutic Perspectives
The global epidemiological transition of chronic liver diseases has consolidated Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD) and its inflammatory form, Metabolic Dysfunction-Associated Steatohepatitis (MASH), as emerging and predominant indications for liver transplantation in the current era1. However, the resolution of end-stage liver failure by surgery exposes the recipient to a new and complex challenge: the "second metabolic hit," induced by continuous immunosuppressive therapy (especially calcineurin inhibitors and corticosteroids). This pharmacological intervention, associated with appetite recovery and improvement in prior nutritional status, triggers accelerated weight gain, development of new-onset diabetes after transplantation (NODAT), dyslipidemia, and recurrent or de novo steatosis in the allograft
- 9 November 2026
- Published by Associacao Brasileira de Transplantes de Orgaos in Brazilian Journal of Transplantation
- p. e4826
Open AccessMultidisciplinary Approach to Post-Liver Transplant Obesity: Challenges and Therapeutic Perspectives
The global epidemiological transition of chronic liver diseases has consolidated Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD) and its inflammatory form, Metabolic Dysfunction-Associated Steatohepatitis (MASH), as emerging and predominant indications for liver transplantation in the current era1. However, the resolution of end-stage liver failure by surgery exposes the recipient to a new and complex challenge: the "second metabolic hit," induced by continuous immunosuppressive therapy (especially calcineurin inhibitors and corticosteroids). This pharmacological intervention, associated with appetite recovery and improvement in prior nutritional status, triggers accelerated weight gain, development of new-onset diabetes after transplantation (NODAT), dyslipidemia, and recurrent or de novo steatosis in the allograft
- 24 July 2025
- Published by Wiley in Clinical Transplantation
- Vol. 39 (8) , e70252
Cultural Influences, Considerations, and Challenges for Organ Donation and Liver Transplantation Around the World
Introduction: Although liver transplantation (LT) rates have increased globally, the demand for organs still exceeds the supply. This review highlights cultures with significant influences on organ donation and LT. Methods: We performed a literature search for articles related to cultures, ethnologies, philosophies, policies, religions, socio‐economic factors, and other influences affecting organ donation in LT around the world. Results: There are astonishing similarities between different cultures. In Africa, Asia, and Europe, people often view the postmortem bodies as sacred and believe that their bodies are gifts from “God” or ancestors. To respect the gift of life, to have a chance in reincarnation, or to enjoy life after death, many believe that their bodily sanctity must be preserved. In Asia, Europe, and Latin America, there is a general reluctance to speak about death. Religions also play an important role in people's views on organ donation. Different regions around the world have similar challenges to organ donation, such as misconceptions about organ trafficking, political and economic instability, and a lack of governmental or religious support. Conclusion: Addressing the complexities of organ donation and LT requires a multifaceted approach. Culturally sensitive education tailored to diverse communities can dispel myths and misconceptions surrounding organ donation. Fostering partnerships between healthcare providers, religious leaders, community organizations, and policymakers can further facilitate open dialogues and promote organ donation as a noble act to save lives. Social Media: Similar cultures around the world post challenges for organ donation. Organizations should foster partnerships between healthcare providers, politicians, and religious leaders to promote donation.
- 24 July 2025
- Published by Wiley in Clinical Transplantation
- Vol. 39 (8) , e70252
Cultural Influences, Considerations, and Challenges for Organ Donation and Liver Transplantation Around the World
Introduction: Although liver transplantation (LT) rates have increased globally, the demand for organs still exceeds the supply. This review highlights cultures with significant influences on organ donation and LT. Methods: We performed a literature search for articles related to cultures, ethnologies, philosophies, policies, religions, socio‐economic factors, and other influences affecting organ donation in LT around the world. Results: There are astonishing similarities between different cultures. In Africa, Asia, and Europe, people often view the postmortem bodies as sacred and believe that their bodies are gifts from “God” or ancestors. To respect the gift of life, to have a chance in reincarnation, or to enjoy life after death, many believe that their bodily sanctity must be preserved. In Asia, Europe, and Latin America, there is a general reluctance to speak about death. Religions also play an important role in people's views on organ donation. Different regions around the world have similar challenges to organ donation, such as misconceptions about organ trafficking, political and economic instability, and a lack of governmental or religious support. Conclusion: Addressing the complexities of organ donation and LT requires a multifaceted approach. Culturally sensitive education tailored to diverse communities can dispel myths and misconceptions surrounding organ donation. Fostering partnerships between healthcare providers, religious leaders, community organizations, and policymakers can further facilitate open dialogues and promote organ donation as a noble act to save lives. Social Media: Similar cultures around the world post challenges for organ donation. Organizations should foster partnerships between healthcare providers, politicians, and religious leaders to promote donation.
- Open Access
- 18 June 2025
- Published by Baishideng Publishing Group Inc. in World Journal of Transplantation
- Vol. 15 (2)
Ten years of a pediatric living donor liver transplantation program in Brazil
BACKGROUND Pediatric living-donor liver transplantation is considered a safe alternative for the treatment of children with end-stage liver disease. Experienced tertiary centers and specialized medical staff are necessary to ensure compatible long-term survival rates and quality-of-life for these children. AIM To report the results and the 10-year learning curve of a pediatric living-donor liver transplantation program. METHODS We conducted a retrospective cohort study of pediatric recipients from 2013 to 2023. Post-transplant outcomes and patient survival rates were compared between two 5-year periods of the program. RESULTS A total of 25 and 48 patients underwent transplantation in the first (2013-2017) and second period (2018-2023), respectively. Portal vein and hepatic artery thrombosis occurred in 11 (15.1%) and seven (9.6%) patients, respectively. Biliary complications were observed in 39 of 73 patients (53.4%). A lower warm ischemia time was observed in the second period compared to the first (32.6 ± 8.6 minutes vs 38.4 ± 9.8 minutes, P = 0.018, respectively). Patient survival rates at 1 and 5 years were 84% in the first period and 91.7% in the second period, with no significant difference (P = 0.32). CONCLUSION The reported indications and outcomes align with the current literature. Our findings provide crucial evidence regarding the feasibility of establishing a living donor program with consistent results over time.
- 18 June 2025
- Published by Baishideng Publishing Group Inc. in World Journal of Transplantation
- Vol. 15 (2)
Open AccessTen years of a pediatric living donor liver transplantation program in Brazil
BACKGROUND Pediatric living-donor liver transplantation is considered a safe alternative for the treatment of children with end-stage liver disease. Experienced tertiary centers and specialized medical staff are necessary to ensure compatible long-term survival rates and quality-of-life for these children. AIM To report the results and the 10-year learning curve of a pediatric living-donor liver transplantation program. METHODS We conducted a retrospective cohort study of pediatric recipients from 2013 to 2023. Post-transplant outcomes and patient survival rates were compared between two 5-year periods of the program. RESULTS A total of 25 and 48 patients underwent transplantation in the first (2013-2017) and second period (2018-2023), respectively. Portal vein and hepatic artery thrombosis occurred in 11 (15.1%) and seven (9.6%) patients, respectively. Biliary complications were observed in 39 of 73 patients (53.4%). A lower warm ischemia time was observed in the second period compared to the first (32.6 ± 8.6 minutes vs 38.4 ± 9.8 minutes, P = 0.018, respectively). Patient survival rates at 1 and 5 years were 84% in the first period and 91.7% in the second period, with no significant difference (P = 0.32). CONCLUSION The reported indications and outcomes align with the current literature. Our findings provide crucial evidence regarding the feasibility of establishing a living donor program with consistent results over time.
- Open Access
- 1 January 2025
- Published by FapUNIFESP (SciELO) in Revista Paulista de Pediatria
- Vol. 43, e2024273
Nutritional outcomes in pediatric liver transplantation: a longitudinal analysis of anthropometric measures
Objective: To evaluate the nutritional outcomes in patients aged zero to 18 undergoing liver transplantation, comparing preoperative and postoperative periods, and to determine the average time required for malnourished patients to reach eutrophy. Methods: This retrospective longitudinal study utilized a non-probabilistic convenience sample of 66 children and adolescents who underwent liver transplantation at a hospital in a Brazilian capital. Anthropometric data (weight, height, and body mass index (BMI)-for-age) were extracted from medical records and expressed as Z-scores according to the World Health Organization (WHO) growth charts for sex and age. Statistical analyses were performed using the paired Student’s t-test and the Kaplan-Meier survival curve. Results: Before the transplant, 43.94% of the patients were malnourished. Following the procedure, significant increases were observed in mean weight (from 12.47 kg to 16.63 kg; p<0.0001), height (from 80.09 cm to 91.51 cm; p<0.0001), and BMI (from 16.60 kg/m2 to 18.29 kg/m2; p<0.0001). The Z-scores for weight-for-age (-1.16 to 0.23; p<0.0001), height-for-age (-1.55 to -1.28; p=0.024), and BMI-for-age (-0.29 to 1.61; p<0.0001) also improved. The average time to reach eutrophy was 228 days. Conclusions: Liver transplantation significantly improved the nutritional outcomes of children and adolescents, as evidenced by improvements in anthropometric parameters. The mean time to reach eutrophy was approximately 7.5 months.
- 1 January 2025
- Published by FapUNIFESP (SciELO) in Revista Paulista de Pediatria
- Vol. 43, e2024273
Open AccessNutritional outcomes in pediatric liver transplantation: a longitudinal analysis of anthropometric measures
Objective: To evaluate the nutritional outcomes in patients aged zero to 18 undergoing liver transplantation, comparing preoperative and postoperative periods, and to determine the average time required for malnourished patients to reach eutrophy. Methods: This retrospective longitudinal study utilized a non-probabilistic convenience sample of 66 children and adolescents who underwent liver transplantation at a hospital in a Brazilian capital. Anthropometric data (weight, height, and body mass index (BMI)-for-age) were extracted from medical records and expressed as Z-scores according to the World Health Organization (WHO) growth charts for sex and age. Statistical analyses were performed using the paired Student’s t-test and the Kaplan-Meier survival curve. Results: Before the transplant, 43.94% of the patients were malnourished. Following the procedure, significant increases were observed in mean weight (from 12.47 kg to 16.63 kg; p<0.0001), height (from 80.09 cm to 91.51 cm; p<0.0001), and BMI (from 16.60 kg/m2 to 18.29 kg/m2; p<0.0001). The Z-scores for weight-for-age (-1.16 to 0.23; p<0.0001), height-for-age (-1.55 to -1.28; p=0.024), and BMI-for-age (-0.29 to 1.61; p<0.0001) also improved. The average time to reach eutrophy was 228 days. Conclusions: Liver transplantation significantly improved the nutritional outcomes of children and adolescents, as evidenced by improvements in anthropometric parameters. The mean time to reach eutrophy was approximately 7.5 months.
- Open Access
- 1 January 2025
- Published by FapUNIFESP (SciELO) in ABCD. Arquivos Brasileiros de Cirurgia Digestiva (São Paulo)
- Vol. 38, e1876
STANDARDIZATION OF THE WHITE TEST IN OPEN LIVER RESECTION: TOWARD NEAR-ZERO CLINICALLY SIGNIFICANT BILE LEAKAGE
BACKGROUND: Biliary fistula is one of the most common complications after liver resection and is associated with significant morbidity and mortality. One of the methods used to evaluate biliary fistulas is the White test, which consists of injecting a lipid emulsion into the bile duct. However, no standard technique for performing the White test has been published.
- 1 January 2025
- Published by FapUNIFESP (SciELO) in ABCD. Arquivos Brasileiros de Cirurgia Digestiva (São Paulo)
- Vol. 38, e1876
Open AccessSTANDARDIZATION OF THE WHITE TEST IN OPEN LIVER RESECTION: TOWARD NEAR-ZERO CLINICALLY SIGNIFICANT BILE LEAKAGE
BACKGROUND: Biliary fistula is one of the most common complications after liver resection and is associated with significant morbidity and mortality. One of the methods used to evaluate biliary fistulas is the White test, which consists of injecting a lipid emulsion into the bile duct. However, no standard technique for performing the White test has been published.
- Open Access
- 7 September 2024
- Published by Baishideng Publishing Group Inc. in World Journal of Gastroenterology
- Vol. 30 (33) , 3837-3845
Human leukocyte antigen compatibility and incidence of donor-specific antibodies in pediatric liver transplant recipients
BACKGROUND Antibody-mediated rejection following liver transplantation (LT) has been increasingly recognized, particularly with respect to the emergence of de novo donor-specific antibodies (DSAs) and their impact on graft longevity. While substantial evidence for adult populations exists, research focusing on pediatric LT outcomes remains limited. AIM To investigate the prevalence of human leukocyte antigen (HLA) mismatches and DSA and evaluate their association with rejection episodes after pediatric LT. METHODS A cohort of pediatric LT recipients underwent HLA testing at Santa Casa de Porto Alegre, Brazil, between December 2013 and December 2023. Only patients who survived for > 30 days after LT with at least one DSA analysis were included. DSA classes I and II and cross-matches were analyzed. The presence of de novo DSA (dnDSA) was evaluated at least 3 months after LT using the Luminex® single antigen bead method, with a positive reaction threshold set at 1000 MFI. Rejection episodes were confirmed by liver biopsy. RESULTS Overall, 67 transplanted children were analyzed; 61 received grafts from living donors, 85% of whom were related to recipients. Pre-transplant DSA (class I or II) was detected in 28.3% of patients, and dnDSA was detected in 48.4%. The median time to DSA detection after LT was 19.7 [interquartile range (IQR): 4.3-35.6] months. Biopsy-proven rejection occurred in 13 patients at follow-up, with C4d positivity observed in 5/13 Liver biopsies. The median time to rejection was 7.8 (IQR: 5.7-12.8) months. The presence of dnDSA was significantly associated with rejection (36% vs 3%, P < 0.001). The rejection-free survival rates at 12 and 24 months were 76% vs 100% and 58% vs 95% for patients with dnDSA anti-DQ vs those without, respectively. CONCLUSION Our findings highlight the importance of incorporating DSA assessment into pre- and post-transplantation protocols for pediatric LT recipients. Future implications may include immunosuppression minimization strategies based on this analysis in pediatric LT recipients.
- 7 September 2024
- Published by Baishideng Publishing Group Inc. in World Journal of Gastroenterology
- Vol. 30 (33) , 3837-3845
Open AccessHuman leukocyte antigen compatibility and incidence of donor-specific antibodies in pediatric liver transplant recipients
BACKGROUND Antibody-mediated rejection following liver transplantation (LT) has been increasingly recognized, particularly with respect to the emergence of de novo donor-specific antibodies (DSAs) and their impact on graft longevity. While substantial evidence for adult populations exists, research focusing on pediatric LT outcomes remains limited. AIM To investigate the prevalence of human leukocyte antigen (HLA) mismatches and DSA and evaluate their association with rejection episodes after pediatric LT. METHODS A cohort of pediatric LT recipients underwent HLA testing at Santa Casa de Porto Alegre, Brazil, between December 2013 and December 2023. Only patients who survived for > 30 days after LT with at least one DSA analysis were included. DSA classes I and II and cross-matches were analyzed. The presence of de novo DSA (dnDSA) was evaluated at least 3 months after LT using the Luminex® single antigen bead method, with a positive reaction threshold set at 1000 MFI. Rejection episodes were confirmed by liver biopsy. RESULTS Overall, 67 transplanted children were analyzed; 61 received grafts from living donors, 85% of whom were related to recipients. Pre-transplant DSA (class I or II) was detected in 28.3% of patients, and dnDSA was detected in 48.4%. The median time to DSA detection after LT was 19.7 [interquartile range (IQR): 4.3-35.6] months. Biopsy-proven rejection occurred in 13 patients at follow-up, with C4d positivity observed in 5/13 Liver biopsies. The median time to rejection was 7.8 (IQR: 5.7-12.8) months. The presence of dnDSA was significantly associated with rejection (36% vs 3%, P < 0.001). The rejection-free survival rates at 12 and 24 months were 76% vs 100% and 58% vs 95% for patients with dnDSA anti-DQ vs those without, respectively. CONCLUSION Our findings highlight the importance of incorporating DSA assessment into pre- and post-transplantation protocols for pediatric LT recipients. Future implications may include immunosuppression minimization strategies based on this analysis in pediatric LT recipients.
- Open Access
- 18 March 2024
- Published by Baishideng Publishing Group Inc. in World Journal of Transplantation
- Vol. 14 (1) , 88734
Primary liver transplantation vs transplant after Kasai portoenterostomy in children with biliary atresia: A retrospective Brazilian single-center cohort
BACKGROUND Biliary atresia (BA) is the most common indication for pediatric liver transplantation, although portoenterostomy is usually performed first. However, due to the high failure rate of portoenterostomy, liver transplantation has been advocated as the primary procedure for patients with BA. It is still unclear if a previous portoenterostomy has a negative impact on liver transplantation outcomes. AIM To investigate the effect of prior portoenterostomy in infants undergoing liver transplantation for BA. METHODS This was a retrospective cohort study of 42 pediatric patients with BA who underwent primary liver transplantation from 2013 to 2023 at a single tertiary center in Brazil. Patients with BA were divided into two groups: Those undergoing primary liver transplantation without portoenterostomy and those undergoing liver transplantation with prior portoenterostomy. Continuous variables were compared using the Student’s t -test or the Kruskal-Wallis test, and categorical variables were compared using the χ 2 or Fisher’s exact test, as appropriate. Multivariable Cox regression analysis was performed to determine risk factors for portal vein thrombosis. Patient and graft survival analyses were conducted with the Kaplan–Meier product-limit estimator, and patient subgroups were compared using the two-sided log-rank test. RESULTS Forty-two patients were included in the study (25 [60%] girls), 23 undergoing liver transplantation without prior portoenterostomy, and 19 undergoing liver transplantation with prior portoenterostomy. Patients with prior portoenterostomy were older (12 vs 8 mo; P = 0.02) at the time of liver transplantation and had lower Pediatric End-Stage Liver Disease scores (13.2 vs 21.4; P = 0.01). The majority of the patients (35/42, 83%) underwent living-donor liver transplantation. The group of patients without prior portoenterostomy appeared to have a higher incidence of portal vein thrombosis (39 vs 11%), but this result did not reach statistical significance. Prior portoenterostomy was not a protective factor against portal vein thrombosis in the multivariable analysis after adjusting for age at liver transplantation, graft-to-recipient weight ratio, and use of vascular grafts. Finally, the groups did not significantly differ in terms of post-transplant survival. CONCLUSION In our study, prior portoenterostomy did not significantly affect the outcomes of liver transplantation.
- 18 March 2024
- Published by Baishideng Publishing Group Inc. in World Journal of Transplantation
- Vol. 14 (1) , 88734
Open AccessPrimary liver transplantation vs transplant after Kasai portoenterostomy in children with biliary atresia: A retrospective Brazilian single-center cohort
BACKGROUND Biliary atresia (BA) is the most common indication for pediatric liver transplantation, although portoenterostomy is usually performed first. However, due to the high failure rate of portoenterostomy, liver transplantation has been advocated as the primary procedure for patients with BA. It is still unclear if a previous portoenterostomy has a negative impact on liver transplantation outcomes. AIM To investigate the effect of prior portoenterostomy in infants undergoing liver transplantation for BA. METHODS This was a retrospective cohort study of 42 pediatric patients with BA who underwent primary liver transplantation from 2013 to 2023 at a single tertiary center in Brazil. Patients with BA were divided into two groups: Those undergoing primary liver transplantation without portoenterostomy and those undergoing liver transplantation with prior portoenterostomy. Continuous variables were compared using the Student’s t -test or the Kruskal-Wallis test, and categorical variables were compared using the χ 2 or Fisher’s exact test, as appropriate. Multivariable Cox regression analysis was performed to determine risk factors for portal vein thrombosis. Patient and graft survival analyses were conducted with the Kaplan–Meier product-limit estimator, and patient subgroups were compared using the two-sided log-rank test. RESULTS Forty-two patients were included in the study (25 [60%] girls), 23 undergoing liver transplantation without prior portoenterostomy, and 19 undergoing liver transplantation with prior portoenterostomy. Patients with prior portoenterostomy were older (12 vs 8 mo; P = 0.02) at the time of liver transplantation and had lower Pediatric End-Stage Liver Disease scores (13.2 vs 21.4; P = 0.01). The majority of the patients (35/42, 83%) underwent living-donor liver transplantation. The group of patients without prior portoenterostomy appeared to have a higher incidence of portal vein thrombosis (39 vs 11%), but this result did not reach statistical significance. Prior portoenterostomy was not a protective factor against portal vein thrombosis in the multivariable analysis after adjusting for age at liver transplantation, graft-to-recipient weight ratio, and use of vascular grafts. Finally, the groups did not significantly differ in terms of post-transplant survival. CONCLUSION In our study, prior portoenterostomy did not significantly affect the outcomes of liver transplantation.
- Open Access
- 18 December 2023
- Published by Baishideng Publishing Group Inc. in World Journal of Transplantation
- Vol. 13 (6) , 290-298
Liver volumetric and anatomic assessment in living donor liver transplantation: the role of modern imaging and artificial intelligence
The shortage of deceased donor organs has prompted the development of alternative liver grafts for transplantation. Living-donor liver transplantation (LDLT) has emerged as a viable option, expanding the donor pool and enabling timely transplantation with favorable graft function and improved long-term outcomes. An accurate evaluation of the donor liver’s volumetry (LV) and anatomical study is crucial to ensure adequate future liver remnant, graft volume and precise liver resection. Thus, ensuring donor safety and an appropriate graft-to-recipient weight ratio. Manual LV (MLV) using computed tomography has traditionally been considered the gold standard for assessing liver volume. However, the method has been limited by cost, subjectivity, and variability. Automated LV techniques employing advanced segmentation algorithms offer improved reproducibility, reduced variability, and enhanced efficiency compared to manual measurements. However, the accuracy of automated LV requires further investigation. The study provides a comprehensive review of traditional and emerging LV methods, including semi-automated image processing, automated LV techniques, and machine learning-based approaches. Additionally, the study discusses the respective strengths and weaknesses of each of the aforementioned techniques. The use of artificial intelligence (AI) technologies, including machine learning and deep learning, is expected to become a routine part of surgical planning in the near future. The implementation of AI is expected to enable faster and more accurate image study interpretations, improve workflow efficiency, and enhance the safety, speed, and cost-effectiveness of the procedures. Accurate preoperative assessment of the liver plays a crucial role in ensuring safe donor selection and improved outcomes in LDLT. MLV has inherent limitations that have led to the adoption of semi-automated and automated software solutions. Moreover, AI has tremendous potential for LV and segmentation; however, its widespread use is hindered by cost and availability. Therefore, the integration of multiple specialties is necessary to embrace technology and explore its possibilities, ranging from patient counseling to intraoperative decision-making through automation and AI.
- 18 December 2023
- Published by Baishideng Publishing Group Inc. in World Journal of Transplantation
- Vol. 13 (6) , 290-298
Open AccessLiver volumetric and anatomic assessment in living donor liver transplantation: the role of modern imaging and artificial intelligence
The shortage of deceased donor organs has prompted the development of alternative liver grafts for transplantation. Living-donor liver transplantation (LDLT) has emerged as a viable option, expanding the donor pool and enabling timely transplantation with favorable graft function and improved long-term outcomes. An accurate evaluation of the donor liver’s volumetry (LV) and anatomical study is crucial to ensure adequate future liver remnant, graft volume and precise liver resection. Thus, ensuring donor safety and an appropriate graft-to-recipient weight ratio. Manual LV (MLV) using computed tomography has traditionally been considered the gold standard for assessing liver volume. However, the method has been limited by cost, subjectivity, and variability. Automated LV techniques employing advanced segmentation algorithms offer improved reproducibility, reduced variability, and enhanced efficiency compared to manual measurements. However, the accuracy of automated LV requires further investigation. The study provides a comprehensive review of traditional and emerging LV methods, including semi-automated image processing, automated LV techniques, and machine learning-based approaches. Additionally, the study discusses the respective strengths and weaknesses of each of the aforementioned techniques. The use of artificial intelligence (AI) technologies, including machine learning and deep learning, is expected to become a routine part of surgical planning in the near future. The implementation of AI is expected to enable faster and more accurate image study interpretations, improve workflow efficiency, and enhance the safety, speed, and cost-effectiveness of the procedures. Accurate preoperative assessment of the liver plays a crucial role in ensuring safe donor selection and improved outcomes in LDLT. MLV has inherent limitations that have led to the adoption of semi-automated and automated software solutions. Moreover, AI has tremendous potential for LV and segmentation; however, its widespread use is hindered by cost and availability. Therefore, the integration of multiple specialties is necessary to embrace technology and explore its possibilities, ranging from patient counseling to intraoperative decision-making through automation and AI.
- 26 March 2023
- Published by Wiley in Pediatric Transplantation
- Vol. 27 (5) , e14515
Multisystem inflammatory syndrome in children (MIS‐C) associated with SARS‐COV‐2 in the immediate post‐transplant period
- 26 March 2023
- Published by Wiley in Pediatric Transplantation
- Vol. 27 (5) , e14515
Multisystem inflammatory syndrome in children (MIS‐C) associated with SARS‐COV‐2 in the immediate post‐transplant period